AKT1 and cancer: Another mechanism of action for the anti-cancer activity of PCA follows the downregulation of the Ras/Akt/NF-kB pathway by targeting activation of RhoB, further leading to a drop in MMP-2-mediated cellular actions in cancer cells (Lin et al., 2011).